Mapping the serum proteome to neurological diseases using whole genome sequencing
Serum proteins are easily accessible biomarkers and drug targets. Here, the authors use whole genome sequencing data to describe the genetic architecture of neurologically-relevant serum proteins and establish causal protein-neurological disease relationships.
Guardado en:
Autores principales: | Grace Png, Andrei Barysenka, Linda Repetto, Pau Navarro, Xia Shen, Maik Pietzner, Eleanor Wheeler, Nicholas J. Wareham, Claudia Langenberg, Emmanouil Tsafantakis, Maria Karaleftheri, George Dedoussis, Anders Mälarstig, James F. Wilson, Arthur Gilly, Eleftheria Zeggini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f5b2a2d19854a24b3c3f873cde81d0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Whole-genome sequencing analysis of the cardiometabolic proteome
por: Arthur Gilly, et al.
Publicado: (2020) -
Whole genome sequencing and imputation in isolated populations identify genetic associations with medically-relevant complex traits
por: Lorraine Southam, et al.
Publicado: (2017) -
Synergistic insights into human health from aptamer- and antibody-based proteomic profiling
por: Maik Pietzner, et al.
Publicado: (2021) -
The transferability of lipid loci across African, Asian and European cohorts
por: Karoline Kuchenbaecker, et al.
Publicado: (2019) -
GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic health
por: Yajie Zhao, et al.
Publicado: (2021)